Drs. Marc Bloomenstein and Doug Devries provide an in-depth analysis of Sjogren's Syndrome, detailing diagnostic challenges, interdisciplinary management approaches, and the syndrome's systemic implications. Then they discuss dry eye treatments, including the use of cyclosporines, lifitegrast, and other emerging therapies. Highlighting the complexities of treatment in the context of Sjogren's Syndrome, it underscores the importance of personalized care strategies and the latest advancements in therapeutic interventions.
This activity, COPE Activity Number 128139, is accredited by COPE for continuing education for optometrists.
COPE Course No.: 90671-TD
Release Date: 04-02-2024
Expiration Date: 04-01-2024
Grant Support Statement
This activity is supported by unrestricted educational grants from Alcon, Dompe, Harrow, Horizon Therapeutics, SightSciences, Tarsus Pharmaceuticals, Inc. and Trukera.
Marc Bloomenstein, OD, FAAO
Director of Optometric Services
Doug Devries, OD
Director and Managing Partner